Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Ravens

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
Stem Cell Reports|November 13, 2018
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human AtriumMarta Lemme, Bärbel M Ulmer, Marc D Lemoine, et al.
Cell Transplantation|April 18, 2012
Differentiation of chromaffin progenitor cells to dopaminergic neuronsVladimir Vukicevic, Janine Schmid, Andreas Hermann, et al.
Frontiers in Physiology|October 26, 2018
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial FibrillationCristina E Molina, Issam H Abu-Taha, Qiongling Wang, et al.
The Journal of Physiology|April 20, 2024
Piezo1 stretch-activated channel activity differs between murine bone marrow-derived and cardiac tissue-resident macrophagesAna Simon-Chica, Alexander Klesen, Ramona Emig, et al.
British Journal of Pharmacology|March 16, 2013
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patientsPeter Molenaar, Torsten Christ, Rizwan I Hussain, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2020
Repurposing mesalazine against cardiac fibrosis in vitroMaximilian Hoffmann, Theresa A Kant, Ramona Emig, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 17, 2021
Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)Michael Nabauer, Michael Oeff, Andrea Gerth, et al.
Journal of Molecular and Cellular Cardiology|December 23, 2008
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillationMaura Greiser, Hans-Ruprecht Neuberger, Erik Harks, et al.
Medical & Biological Engineering & Computing|December 4, 2014
Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillationUrsula Ravens, Deniz Katircioglu-Öztürk, Erich Wettwer, et al.
Scientific Reports|June 9, 2017
Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytesGökhan Yücel, Zhihan Zhao, Ibrahim El-Battrawy, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Stem Cell Reports|November 13, 2018
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human AtriumMarta Lemme, Bärbel M Ulmer, Marc D Lemoine, et al.
Cell Transplantation|April 18, 2012
Differentiation of chromaffin progenitor cells to dopaminergic neuronsVladimir Vukicevic, Janine Schmid, Andreas Hermann, et al.
Frontiers in Physiology|October 26, 2018
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial FibrillationCristina E Molina, Issam H Abu-Taha, Qiongling Wang, et al.
The Journal of Physiology|April 20, 2024
Piezo1 stretch-activated channel activity differs between murine bone marrow-derived and cardiac tissue-resident macrophagesAna Simon-Chica, Alexander Klesen, Ramona Emig, et al.
British Journal of Pharmacology|March 16, 2013
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patientsPeter Molenaar, Torsten Christ, Rizwan I Hussain, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2020
Repurposing mesalazine against cardiac fibrosis in vitroMaximilian Hoffmann, Theresa A Kant, Ramona Emig, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 17, 2021
Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)Michael Nabauer, Michael Oeff, Andrea Gerth, et al.
Journal of Molecular and Cellular Cardiology|December 23, 2008
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillationMaura Greiser, Hans-Ruprecht Neuberger, Erik Harks, et al.
Medical & Biological Engineering & Computing|December 4, 2014
Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillationUrsula Ravens, Deniz Katircioglu-Öztürk, Erich Wettwer, et al.
Scientific Reports|June 9, 2017
Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytesGökhan Yücel, Zhihan Zhao, Ibrahim El-Battrawy, et al.
Pageof 20